Product Information
ACETAMINOPHEN-COD #4 TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.3890 per EA under NDC 71930005652. Its NADAC has been published 365 times since Oct 9, 2019.
FDA first approved this application on Jun 27, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 60 mg/1; mg/1
Manufacturer
Eywa Pharma IncNDC
71930005652
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211610FDA Approved
6/27/2019
TE Code
AA
On Market Since
8/2/2019
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #4 TABLET has been published 365 times since Oct 9, 2019, and over the history we have for it it has risen 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3890 per EA |
|---|---|
| All-time high | $0.4850 (Jul 10, 2024) |
| All-time low | $0.1905 (Jul 21, 2021) |
| 52-week high | $0.4473 |
| 52-week low | $0.3774 |
| Median price | $0.3417 |
| Average price | $0.3160 |
| Largest weekly change | +39.0% (Dec 21, 2022) |
| Weeks tracked | 365 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eywa Pharma Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
acetaminophen and codeine phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #4 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #4 TABLET, manufactured by Eywa Pharma Inc, is $0.3890 per EA (NDC 71930005652), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN-COD #4 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #4 TABLET has risen 75.2%. It has been tracked across 365 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #4 TABLET?
Since Oct 9, 2019, the NADAC for ACETAMINOPHEN-COD #4 TABLET has ranged from a low of $0.1905 (Jul 21, 2021) to a high of $0.4850 (Jul 10, 2024), with a median of $0.3417 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #4 TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACETAMINOPHEN-COD #4 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETAMINOPHEN-COD #4 TABLET?
ACETAMINOPHEN-COD #4 TABLET (NDC 71930005652) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.